Background: Alzheimer's disease (AD), the most common form of degenerative dementia,
represents a tremendous unmet medical need. Although AD had already been described …

Alzheimer's disease (AD) is one of the neurodegenerative diseases that led to morbidity and
mortality world-wide. It is a complex disease whose etiology is not completely known that …

Abstract Alzheimer′ s disease (AD), a neurodegenerative disease responsible for death of
millions of people worldwide is a progressive clinical disorder which causes neurons to …

Alzheimer's Disease (AD) is a global public health priority characterized by high mortality
rates in adults and an increasing prevalence in aging populations worldwide. Despite …

Alzheimer's disease (AD), a progressive, degenerative disorder of the brain, is believed to
be the most common cause of dementia amongst the elderly. AD is characterized by the …

Among the various drug discovery methods, a very promising modern approach consists in
designing multi-target-directed ligands (MTDLs). This methodology has been specifically …

First described by Alois Alzheimer in 1907, Alzheimer's disease (AD) is the most common
dementia type, affecting approximately 20 million people worldwide. As the population is …

Introduction: Alzheimer's disease (AD) is a daunting public health threat that has prompted
the scientific community's ongoing efforts to decipher the underlying disease mechanism …

Alzheimer's disease (AD) is a chronic neurodegenerative disease, which is considered as
one of the most intractable medical problems with heavy social and economic costs. The …

In the neuroscience landscape, there is no condition with higher unmet medical and societal
need than Alzheimer's disease (AD). There are significant opportunities to improve upon …